Global phage therapy study shows 77% success rate

A groundbreaking international study coordinated by Dr. Jean-Paul Pirnay of the Queen Astrid Military Hospital (Belgium) analyzed 100 consecutive real-world cases of phage therapy. The results are promising: 77% of patients with difficult-to-treat infections showed clinical improvement, especially when phages were combined with antibiotics. This study marks a major step forward in the fight against antimicrobial resistance.

The Phage Valley hosts back-to-back phage conferences this September

This September, Phage Valley becomes the epicenter of phage science with two major events. First is The Phage Protein Meeting, focusing on the development of phage proteins for biocontrol and therapy. Just one day later, the 4th Annual Symposium of the Belgian Society for Viruses of Microbes (BSVoM) will highlight the latest advances in virus-of-microbe research. These consecutive conferences underscore Phage Valley’s growing role as a global hub for phage innovation.